SpacePharma is a Swiss-Israeli biotechnology company founded in 2012 that develops miniaturized, remotely controlled laboratories for conducting pharmaceutical research and development in microgravity on satellites and the International Space Station. They offer services including microgravity research, in-space manufacturing, and development of microfluidic systems. SpacePharma partners with organizations like SpaceX, Arianespace, and the International Space University, serving life science, pharma, and biotech companies. Key products and services include miniaturized labs like SPMG, NEXUS, and SPAd, and the SPACTORY, their operational space factory.
All verified mentions of this organization in source documents.
SpacePharma provided the miniaturized medical laboratory payload for DIDO-3 and provides end-to-end microgravity services for medical drug development in space.
The DIDO-3 payload is a miniaturized medical laboratory provided by the customer SpacePharma, which provides end-to-end microgravity services for medical drug development research in space.
DIDO-3 is a satellite built by ISISPACE with a payload from Spacepharma that contains temperature-sensitive microgravity experiments.
Spacety has five or six customers at institutes under the Chinese Academy of Sciences conducting experiments, including microgravity science research in cooperation with SpacePharma on a satellite launched in February 2017.
RBC Signals reached an agreement in March to gain access to a ground station network in Courgenay, Switzerland operated by SpacePharma SA.
DIDO-3 will feature several advancements compared to DIDO-2 to increase payload performance and enable SpacePharma to host more advanced experiments.
SpacePharma SA selected ISIS – Innovative Solutions In Space B.V. to build the platform and integrate the payload for the DIDO-3 mission with support for satellite commissioning after launch.